These effects, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 guidance the thought of targeting ACKR3 as a unique solution to modulate the opioid method, which could open new therapeutic avenues for opioid-linked Diseases. By ticking this box and publishing https://theodorez036lnm6.activablog.com/profile